We’re proud to announce that the results of our randomized controlled trial (RCT) were published in the February 2025 issue of the Clinical Journal of Oncology Nursing—and featured on the …
oVRcome has received IRB approval of our study to investigate the ability of virtual reality to function as a novel distraction intervention and improve the experience of patients who are …